Active Clinical Trials

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer

By April 24, 2017 No Comments

Condition

Lung Cancer|Lung Cancer Non-Small Cell Cancer (NSCLC)|Lung Cancer Small Cell Lung Cancer (SCLC)|Mesothelioma

Estimated Enrollment: 12

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Diagnostic

Study ID Numbers: LUN0040|18395

Study First Received: August 23, 2010

Last Updated: July 7, 2016

Estimated Primary Completion Date: July 2016

 

Primary Outcome Measures:

– Feasibility and safety of identification of primary nodal drainage for purpose of radiation therapy targeting|- Feasibility of incorporating primary nodal drainage into radiation therapy planning process

Sponsors and Collaborators:

Stanford University

Website Link: https://ClinicalTrials.gov/show/NCT01188486

Leave a Reply

Call Now ButtonCall Now